ZNF703 was recently identified as a novel breast cancer oncogene in the 15% of breast cancers that harbor 8p12 amplifications, amplified second only to the well-known oncogenes, ERBB2 and cyclin D1 (CCND1) [25], [26]. Here, ERBB2 is linked to breast cancer.